vs

Side-by-side financial comparison of ASBURY AUTOMOTIVE GROUP INC (ABG) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $4.1B, roughly 1.1× ASBURY AUTOMOTIVE GROUP INC). Emerson Electric runs the higher net margin — 13.9% vs 4.6%, a 9.4% gap on every dollar of revenue. On growth, Emerson Electric posted the faster year-over-year revenue change (4.1% vs -0.9%). Over the past eight quarters, Emerson Electric's revenue compounded faster (-0.3% CAGR vs -1.6%).

Asbury Automotive Group is an American company based in the Atlanta area that operates auto dealerships in various parts of the United States. Founded in 1995, it was ranked No. 242 on the 2025 Fortune 500 list.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

ABG vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.1× larger
EMR
$4.3B
$4.1B
ABG
Growing faster (revenue YoY)
EMR
EMR
+5.0% gap
EMR
4.1%
-0.9%
ABG
Higher net margin
EMR
EMR
9.4% more per $
EMR
13.9%
4.6%
ABG
Faster 2-yr revenue CAGR
EMR
EMR
Annualised
EMR
-0.3%
-1.6%
ABG

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ABG
ABG
EMR
EMR
Revenue
$4.1B
$4.3B
Net Profit
$187.8M
$605.0M
Gross Margin
17.7%
53.2%
Operating Margin
4.7%
17.8%
Net Margin
4.6%
13.9%
Revenue YoY
-0.9%
4.1%
Net Profit YoY
42.2%
3.4%
EPS (diluted)
$9.87
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABG
ABG
EMR
EMR
Q1 26
$4.1B
Q4 25
$4.7B
$4.3B
Q3 25
$4.8B
$4.9B
Q2 25
$4.4B
$4.6B
Q1 25
$4.1B
$4.4B
Q4 24
$4.5B
$4.2B
Q3 24
$4.2B
$4.6B
Q2 24
$4.2B
$4.4B
Net Profit
ABG
ABG
EMR
EMR
Q1 26
$187.8M
Q4 25
$60.0M
$605.0M
Q3 25
$147.1M
$637.0M
Q2 25
$152.8M
$586.0M
Q1 25
$132.1M
$485.0M
Q4 24
$128.8M
$585.0M
Q3 24
$126.3M
$996.0M
Q2 24
$28.1M
$329.0M
Gross Margin
ABG
ABG
EMR
EMR
Q1 26
17.7%
Q4 25
17.0%
53.2%
Q3 25
16.7%
51.9%
Q2 25
17.2%
52.6%
Q1 25
17.5%
53.5%
Q4 24
16.6%
53.5%
Q3 24
16.9%
51.3%
Q2 24
17.2%
52.8%
Operating Margin
ABG
ABG
EMR
EMR
Q1 26
4.7%
Q4 25
2.7%
17.8%
Q3 25
5.1%
16.4%
Q2 25
5.9%
16.1%
Q1 25
5.6%
14.2%
Q4 24
5.3%
18.6%
Q3 24
5.5%
14.7%
Q2 24
2.4%
10.4%
Net Margin
ABG
ABG
EMR
EMR
Q1 26
4.6%
Q4 25
1.3%
13.9%
Q3 25
3.1%
13.1%
Q2 25
3.5%
12.9%
Q1 25
3.2%
10.9%
Q4 24
2.9%
14.0%
Q3 24
3.0%
21.6%
Q2 24
0.7%
7.5%
EPS (diluted)
ABG
ABG
EMR
EMR
Q1 26
$9.87
Q4 25
$3.14
$1.07
Q3 25
$7.52
$1.12
Q2 25
$7.76
$1.04
Q1 25
$6.71
$0.86
Q4 24
$6.53
$1.02
Q3 24
$6.37
$1.74
Q2 24
$1.39
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABG
ABG
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$25.3M
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$3.9B
$20.3B
Total Assets
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABG
ABG
EMR
EMR
Q1 26
$25.3M
Q4 25
$500.0K
Q3 25
$900.0K
Q2 25
$2.8M
Q1 25
$6.6M
Q4 24
$14.4M
Q3 24
$9.0M
Q2 24
$10.5M
Total Debt
ABG
ABG
EMR
EMR
Q1 26
Q4 25
$3.1B
$7.6B
Q3 25
$3.5B
$8.9B
Q2 25
$3.0B
$8.3B
Q1 25
$3.0B
$8.2B
Q4 24
$3.0B
$6.6B
Q3 24
$3.3B
$7.7B
Q2 24
$3.5B
$7.1B
Stockholders' Equity
ABG
ABG
EMR
EMR
Q1 26
$3.9B
Q4 25
$3.9B
$20.3B
Q3 25
$3.9B
$20.3B
Q2 25
$3.8B
$19.9B
Q1 25
$3.6B
$19.2B
Q4 24
$3.5B
$20.5B
Q3 24
$3.4B
$21.6B
Q2 24
$3.3B
$20.8B
Total Assets
ABG
ABG
EMR
EMR
Q1 26
Q4 25
$11.6B
$41.9B
Q3 25
$11.8B
$42.0B
Q2 25
$10.1B
$42.5B
Q1 25
$10.2B
$42.0B
Q4 24
$10.3B
$42.6B
Q3 24
$10.2B
$44.2B
Q2 24
$10.3B
$45.6B
Debt / Equity
ABG
ABG
EMR
EMR
Q1 26
Q4 25
0.79×
0.37×
Q3 25
0.90×
0.44×
Q2 25
0.78×
0.42×
Q1 25
0.83×
0.42×
Q4 24
0.86×
0.32×
Q3 24
0.98×
0.36×
Q2 24
1.05×
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABG
ABG
EMR
EMR
Operating Cash FlowLast quarter
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABG
ABG
EMR
EMR
Q1 26
Q4 25
$151.9M
$699.0M
Q3 25
$306.9M
$3.1B
Q2 25
$91.4M
$1.1B
Q1 25
$225.0M
$241.0M
Q4 24
$244.2M
$777.0M
Q3 24
$404.3M
$3.3B
Q2 24
$-154.4M
$1.1B
Free Cash Flow
ABG
ABG
EMR
EMR
Q1 26
Q4 25
$602.0M
Q3 25
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$998.0M
FCF Margin
ABG
ABG
EMR
EMR
Q1 26
Q4 25
13.9%
Q3 25
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
22.8%
Capex Intensity
ABG
ABG
EMR
EMR
Q1 26
Q4 25
2.2%
Q3 25
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
2.1%
Cash Conversion
ABG
ABG
EMR
EMR
Q1 26
Q4 25
2.53×
1.16×
Q3 25
2.09×
4.86×
Q2 25
0.60×
1.83×
Q1 25
1.70×
0.50×
Q4 24
1.90×
1.33×
Q3 24
3.20×
3.35×
Q2 24
-5.49×
3.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABG
ABG

New vehicle$2.1B51%
Retail$1.1B26%
Parts and service$626.8M15%
Finance and insurance, net$179.0M4%
Wholesale$146.8M4%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons